Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Mito, Jeffrey K ^a   Riedel, Richard F ^a   Dodd, Leslie ^a   Lahat, Guy ^b   Lazar, Alexander J ^b   Dodd, Rebecca D ^a   Stangenberg, Lars ^c   Eward, William C ^a   Hornicek, Francis J ^c   Yoon, Sam S ^c   Brigman, Brian E ^a   Jacks, Tyler ^d,e   Lev, Dina ^a   Mukherjee, Sayan ^a,f   Kirsch, David G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; GENOME; GENOMICS; GENOTYPE; HUMAN; MALIGNANT FIBROUS HISTIOCYTOMA; METABOLISM; METASTASIS; METHODOLOGY; MICROARRAY ANALYSIS; MOUSE; SARCOMA; SOFT TISSUE TUMOR; SPECIES DIFFERENCE; TUMOR SUPPRESSOR GENE;

ANIMALS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENES, P53; GENOME; GENOMICS; GENOTYPE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MICE; MICROARRAY ANALYSIS; NEOPLASM METASTASIS; SARCOMA; SOFT TISSUE NEOPLASMS; SPECIES SPECIFICITY;

EID: 77951230709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008075     Document Type: Article

References (20)

1. Ozzello L, Stout AP, Murray MR, (1963) Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16: 331-344.
2. Fletcher CD, (1992) Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol 16: 213-228.
3. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M, (2001) Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19: 3045-3050.
4. Hollowood K, Fletcher CD, (1995) Malignant fibrous histiocytoma: morphologic pattern or pathologic entity? Semin Diagn Pathol 12: 210-220.
5. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, et al.(2007) A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13: 992-997.
6. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
7. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al.(2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
8. Baird K, Davis S, Antonescu CR, Harper UL, Walker RL, et al.(2005) Gene expression profiling of human sarcomas: insights into sarcoma biology. Cancer Res 65: 9226-9235.
9. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, et al.(2005) Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 65: 5881-5889.
10. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, et al.(2007) Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 20: 749-759.
11. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al.(2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
12. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
13. Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al.(2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
14. Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR, (2007) A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 11: 375-388.
15. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, et al.(1993) p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231-2234.
16. Yoo J, Robinson RA, (1999) H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients. Cancer 86: 58-63.
17. Yoo J, Robinson RA, Lee JY, (1999) H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes. Mod Pathol 12: 775-780.
18. Liu M, Dai B, Kang SH, Ban K, Huang FJ, et al.(2006) FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 66: 3593-3602.
19. Ma RY, Tong TH, Cheung AM, Tsang AC, Leung WY, et al.(2005) Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c. J Cell Sci 118: 795-806.
20. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, et al.(2008) FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 283: 20770-20778.